The U.K. has officially imposed an indefinite ban on puberty blockers for treating transgender youth, citing safety concerns despite support from global medical organizations.
Health and Social Care Secretary Wes Streeting emphasized that healthcare for children must be evidence-led, citing Dr. Cass's review which highlighted safety risks in current care pathways.
Dr. Hilary Cass's review raised significant safety concerns regarding puberty blockers, emphasizing the lack of solid evidence supporting their use for treating gender dysphoria.
While the indefinite ban halts routine prescriptions, existing users can continue their treatment, and new trials for children with early-onset puberty are planned.
Collection
[
|
...
]